Importance Risk stratification of patients with nonischemic dilated cardiomyopathy is
primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may …

Objectives The purpose of this study was to assess whether the presence and extent of
fibrosis changes over time in patients with nonischemic, dilated cardiomyopathy (DCM) …

Objectives: We studied the prognostic implications of midwall fibrosis in dilated
cardiomyopathy (DCM) in a prospective longitudinal study. Background: Risk stratification of …

Aims Patients with non-ischemic systolic heart failure have an increased risk of sudden
cardiac death (SCD). Myocardial fibrosis, detected as late gadolinium enhancement (LGE) …

Background—We conducted a prospective longitudinal study to investigate the yet unknown
clinical significance of myocardial fibrosis in patients with non–ischemic cardiomyopathy …

Background The presence of focal myocardial fibrosis, also called scar or replacement
fibrosis, detected with late gadolinium enhancement (LGE) cardiovascular magnetic …

Background Current risk stratification for sudden cardiac death (SCD) in nonischemic dilated
cardiomyopathy (NIDC) relies on left ventricular (LV) dysfunction, a poor marker of …

Background—Late gadolinium enhancement-cardiac magnetic resonance is increasingly
performed in patients with systolic dysfunction. Numerous patterns of fibrosis are commonly …

Objectives: The purpose of this study was to evaluate the association between regional
myocardial fibrosis and ventricular arrhythmias in patients with cardiomyopathy …

Myocardial fibrosis is a common pattern in the setting of different heart diseases, and
promotes ventricular tachyarrhythmias by creating a vulnerable substrate for reentrant …